Emerging Trends in Personalized Medicine
The Emerging Trends in Personalized Medicines journal by STM Journals is a peer-reviewed academic publication dedicated to the latest research and innovations in personalized medicine. This journal offers a vital platform for researchers, educators, nursing and public health professionals, and students to explore breakthroughs in tailored therapies, pharmacogenomics, and precision healthcare approaches.
What This Journal Covers: Key Focus Areas
-
Pharmacogenomics and genomic medicine applications
-
Development of individualized therapeutic strategies
-
Advances in biomarker discovery and validation
-
Personalized diagnostics and prognostics
-
Precision oncology and targeted cancer therapies
Who Should Read This Journal
-
Biomedical and clinical researchers focused on tailored therapies
-
Healthcare professionals implementing personalized treatment plans
-
Public health specialists integrating genomics into population health
-
Educators and students in medicine, pharmacy, and health sciences
-
Pharmaceutical developers and biotechnology innovators
Why This Journal Matters
Personalized medicine represents a transformative shift towards more precise, effective, and patient-centered healthcare. This journal:
-
Highlights cutting-edge research that improves treatment customization
-
Bridges the gap between laboratory discoveries and clinical practice
-
Promotes understanding of genetic and environmental influences on health
-
Supports ethical and policy discussions crucial to implementation
-
Advances education and professional competence in an evolving field
Why Choose STM Journals?
STM Journals ensures each publication reflects high academic standards via:
-
Rigorous double-blind peer review guaranteeing quality and reliability
-
Extensive global reach connecting researchers, clinicians, and institutions
-
Flexible access through both online and print formats worldwide
-
Support from an expert editorial board deeply engaged in personalized medicine
Subscription and Access Options
Subscribers to Emerging Trends in Personalized Medicines benefit from:
-
Online Access: Immediate and comprehensive access to the latest and archived issues on STM Journals’ secure digital platform.
-
Print Subscription: Physical copies for libraries, institutions, and individuals preferring traditional formats.
Institutional subscriptions and bulk purchase options are available, tailored to meet various academic and professional needs.
About Journal
Emerging Trends in Personalized Medicines [3049-1347(e)] is a peer-reviewed online journal launched in 2024 that aims to unite all facets of personalized medicine under one platform. Case studies, well-liked articles, research papers, and reviews are all published by it. Molecular and translational sciences, systems biology pharmacogenomics/proteomics, omics association analysis, therapies and diagnostics, discussions of regulatory, social, ethical, and policy concerns, etc. are only a few of the scientific disciplines that are advanced by the publication of papers in the interdisciplinary journal personalized medicine. Researchers are expected to report their theoretical and empirical findings in as much detail as appropriate. As a result, there is no restriction on the paper’s length. To enable the replication of the findings, appropriate theoretical and simulation information must be available.
View Editorial Board
Journal Information
| Title: |
Emerging Trends in Personalized Medicines |
Abbreviation: |
ETPM |
| Issues Per Year: |
2 Issues |
E-ISSN: |
3049-1347 |
| Publisher: |
STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. |
| DOI: |
10.37591/ETPM |
Starting Year: |
2024 |
| Language: |
English |
Publication Format: |
Hybrid Open Access |
| Subject: |
Personalized Medicines |
Type: |
Peer-reviewed Journal (Refereed Journal) |
| Copyright Policy: |
CC BY-NC-ND |
Indexing & Metrics
Indexing: Google Scholar, Scientific Literature (SCILIT)
ICV Value: 2024: 45.62
Impact Factor (SJIF): 2024: 3.193
Focus & Scope
Focus & Scope
A multidisciplinary precision medicine framework—integrating pharmacogenomics, multi-omics research, and advanced cell therapies with clinical decision support and ethical governance.
Oncology & Targeted Therapy
Focus on folate receptor targeting (Vintafolide) for ovarian and lung cancer. Utilizing microfluidics, tumor organoids, and circulating tumor cells to map K-Ras signaling pathways and identify small molecule drug conjugates.
Genetic & Healthcare Integration
Application of SNPs, CNVs, and transcript profiling to tailor drug metabolizing enzymes. Research spans clinical decision support in anesthesiology and multimodal analgesia based on a patient’s unique genetic makeup.
Advanced Cell & Gene Therapy
Personalizing stem cell treatments for chronic wounds and inflammation. Leveraging gene transfer, vaccine development, and cancer stem cell markers to drive progress in regenerative medicine and skin healing.
Neuroscience & Immunology
Molecular profiling for Alzheimer’s and Parkinson’s using organ-on-chip technology. Investigating antibody diversity, immunogenicity testing, and mTORC pathways to treat vasculopathy and neurological disorders.
Bioinformatics & Multi-Omics
Integrating proteomics, lipidomics, and metabolomics to identify gene signatures via NGS. Using machine learning and Bayesian ranking to discover drug targets and optimize nutritional surveillance through gut microbiota analysis.
Governance & Bio-Informatics
Exploring the morality of big data, health care regulation, and “soft law” governance. Addressing the consumerization of personal genomics and the responsibilization of patients within new disease taxonomies.
